MedCity News October 24, 2021
Elise Reuter

CVS Caremark recently launched efforts to better prevent, detect and treat sickle cell disease, HIV and cardiovascular disease. CVS Caremark CMO Sree Chaguturu shared how the PBM launched this effort at the engagement track at HLTH, hosted by MedCity News

In the last two years, many health plans have turned an eye to health disparities magnified by the pandemic. But how do you actually address the impact of these structural inequities on people’s health?

CVS Caremark is starting by focusing on addressing inequities across three conditions: sickle cell disease, HIV and cardiovascular disease. The company’s goal is to improve awareness, access to health services and treatment.

“What we see with health disparities is that there are structural challenges to helping...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Equity/SDOH, Healthcare System, Pharma, Pharma / Biotech, Trends
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth

Share This Article